ORiordan Anne's Form 4 filing
Jazz Pharmaceuticals plc (JAZZ) · filed May 11, 2022
- Accession no.
- 0001765581-22-000051
- Filed
- May 11, 2022
- Trade date
- May 9, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $69.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| ORiordan AnneCIK 0001767870 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 9, 2022 | Ordinary Shares | SSaleDisposed | −457 | $148.92 | −$68,056.44 | 9,254 | Direct | |
| May 9, 2022 | Ordinary Shares | SSaleDisposed | −9 | $150.49 | −$1,354.41 | 9,245 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.